Cargando…
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
The deregulation of Wnt signaling is observed in various cancers, including gliomas, and might be related to the methylation of the genes encoding antagonists of this signaling pathway. The aim of the study was to assess the methylation status of the promoter regions of six Wnt negative regulators a...
Autores principales: | Majchrzak-Celińska, Aleksandra, Słocińska, Marta, Barciszewska, Anna-Maria, Nowak, Stanisław, Baer-Dubowska, Wanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830852/ https://www.ncbi.nlm.nih.gov/pubmed/26337424 http://dx.doi.org/10.1007/s13353-015-0312-7 |
Ejemplares similares
-
DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
por: Liu, Xinyan, et al.
Publicado: (2019) -
Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015) -
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2013) -
Promoter Methylation of SFRP3 Is Frequent in Hepatocellular Carcinoma
por: Lin, Ya-Wen, et al.
Publicado: (2014) -
DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015)